Crossmark

Effectiveness of a 10% imidacloprid/4.5% flumethrin polymer matrix collar in reducing the risk of Bartonella spp. infection in privately owned cats

Crossref DOI link: https://doi.org/10.1186/s13071-018-3257-y

Published Online: 2019-02-01

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Greco, Grazia https://orcid.org/0000-0002-4338-6746
Brianti, Emanuele

Buonavoglia, Canio

Carelli, Grazia

Pollmeier, Matthias

Schunack, Bettina

Dowgier, Giulia

Capelli, Gioia

Dantas-Torres, Filipe

Otranto, Domenico
License Information

Text and Data Mining valid from 2019-02-01
More Information

Article History

Received: 16 August 2018

Accepted: 5 December 2018

First Online: 1 February 2019

Ethics approval and consent to participate

: The present study complied with Good Clinical Practice (VICH GL9 GCP). The Italian Ministry of Health approved both protocol and procedures (authorization no. 0006088-10/03/2015-DGSAF-COD_UO- P). Animals were enrolled in the study after their owners signed an informed consent form.

: Not applicable.

: MP and BS are employees of Bayer Animal Health GmbH, which funded the study. GG, EB, CB, GC, GD, GC, FDT and DO declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.